Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

Current Drug Metabolism - United Arab Emirates
doi 10.2174/138920011798062346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Genetic Biomarkers in the VEGF Pathway Predicting Response to Anti-Vegf Therapy in Age-Related Macular Degeneration

BMJ Open Ophthalmology
Ophthalmology
2019English

Ocular Anti-Vegf Therapy for Diabetic Retinopathy: Overview of Clinical Efficacy and Evolving Applications

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

One-Year Outcomes Comparing Anti-Vegf Monotherapy and Combined Anti-VEGF+Photodynamic Therapy for Retinal Angiomatous Proliferation

Beyoglu Eye Journal
2017English

Anti-Vegf Therapy in Breast and Lung Mouse Models of Cancers

Journal of Biomedicine and Biotechnology
2011English

Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’

British Journal of Cancer
Cancer ResearchOncology
2017English

Anti-Vegf Therapy in Central Retinal Vein Occlusions

International Journal of Retina
2018English

Identification and Analysis of in Vivo VEGF Downstream Markers Link VEGF Pathway Activity With Efficacy of Anti-Vegf Therapies

Clinical Cancer Research
Cancer ResearchOncology
2013English

Skin Toxicity Ant Anti-Egfr-Therapy: A Mock Trouble for Elderly and Frail Patients With McRc

Annals of Hematology & Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy